Abstract
SMBG and Telemonitoring participants used the Glucometer for blood glucose analysis that enabled patients to record profile on 3 consecutive days prior to each scheduled study visit. ACG used to visit clinic/ hospital for regular blood glucose monitoring and follow-up as per schedule. All Participants received training in the use of the glucometer and instructions how to identify glycemic patterns and how to resolve them by changes in physical activity, portion sizes, and/or meal composition. Telemonitoring means measurement of BG at home and reports are sent by the text message or by email. Patients put on telemonitoring group were instructed to measure their BG, weight at home and report it by email or by telephone. Their data was entered in the Excel sheet and was interpreted. Any minor modification in treatment or in diet was communicated through email or telephone. Data was continuously monitored by the treating physician and instructions were inserted on the excel sheet.
480 patients screened, 374 (SMBG =123, TMG= 125, ACG =126) were eligible and were enrolled in the study. Of these 10 (SMBG =4, TMG= 3, ACG =3) patients doesn’t gave consent and 15(SMBG =4, TMG= 6, ACG =5 ) patients were lost to follow up . So data of total 349 patients was collected, interpreted and analysed. Total 115 patients in SMBG 38.26% were below 50 years age and 61.74% were above 50 years age group, similarly in TMG and ACG group <50: >50 percentage was 41.38%: 58.62% and 41.43%:58.47% respectively.
Male to female percentage in SMBG was 60% and 40 %, while in TMG it was 61.21% and 38.79 % respectively. Percentage in ACG of male and female patients was 62.71% and 37.29% respectively. Percentage of patients put on single drug or on dietary treatment in SMBG, TMG and ACG was 46.96%, 58.62% and 56.78% respectively, while percentage of patients on 2 or more drugs in in SMBG, TMG and ACG was 53.04%, 41.38% and 43.22% respectively.
References
- UK prospective diabetes study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991; 34:877-90.
- International Diabetes Federation. Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation (IDF); 2014.
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 9; 359(15):1577-89.
- American Diabetes Association. Standards of medical care in diabetes–2010. Diabetes Care 2009;32(Suppl. 1):S4–S10
- Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial.BMJ. 2007 Jul 21; 335(7611):132.
- Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives.BMJ. 2007 Sep 8; 335(7618):493.
- Welsh JB, Myers SJ, Uhrinak AN, Kaufman FR, Lee SW.User acceptability and perceived benefits of new reports in CareLink Pro 3.0 Therapy Management Software for Diabetes.J Diabetes Sci Technol. 2012 Mar 1; 6(2):481-2.
- John C. Choudhary, Stefano Genovese, Gérard Reach. Blood Glucose Pattern Management in Diabetes: Creating Order from Disorder. J Diabetes Sci Technol. 2013 Nov; 7(6): 1575–1584.
- Saffari M, Ghanizadeh G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2014 Dec; 8(4):275-85.
- Spollet RS. Self-monitoring of blood glucose: an underutilized tool. Clin Diabetes. 2010;28(3):127-129.
- Rankin D, Cooke DD, Heller S, Elliott J, Amiel S, Lawton J, UK National Institute for Health Research (NIHR) Dose Adjustment for Normal Eating (DAFNE) Study Group.Experiences of using blood glucose targets when following an intensive insulin regimen: a qualitative longitudinal investigation involving patients with Type 1 diabetes.Diabet Med. 2012 Aug; 29(8):1079-84.
- Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.BMJ. 2012 Feb 27; 344():e486.
- Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association., American College of Cardiology Foundation., American Heart Association Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care.2009 Jan; 32(1):187-92.
- Marcolino MS, Maia JX, Alkmim MB, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013; 8(11):e79246.
Dr Pradeep Kumar Shukla
Assistant Professor Dept. of Medicine, Teerthankar Mahaveer Medical College & Research Centre Moradabad, India
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.108
